Richard Wooster - Jan 21, 2022 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Richard Wooster
Stock symbol
IKNA
Transactions as of
Jan 21, 2022
Transactions value $
$0
Form type
4
Date filed
1/25/2022, 08:34 PM
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +29.2K $0.00 29.2K Jan 21, 2022 Common Stock 29.2K $11.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in equal installments on the first, second, and third anniversaries of the grant date.